1-17 of 17
Noopur Raje, MD
Close
Sort by
Articles

Best of 2017 in Multiple Myeloma

Noopur Raje, MD, Andrew J. Yee, MD
Journal: The Hematologist
The Hematologist (2018) 15 (1)
https://doi.org/10.1182/hem.V15.1.8179
Published: 2018
Articles

Programming Myeloma Cell Death With Venetoclax

Noopur Raje, MD, Andrew J. Yee, MD
Journal: The Hematologist
The Hematologist (2017) 14 (6)
https://doi.org/10.1182/hem.V14.6.7792
Published: 2017
Articles

Combining PD-1 Inhibition With Pemalidomide for Relapsed/Refractory Multiple Myeloma

Elizabeth O'Donnell, MD, Noopur Raje, MD
Journal: The Hematologist
The Hematologist (2017) 14 (5)
https://doi.org/10.1182/hem.V14.5.7617
Published: 2017
Articles

Is Upfront Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma the Standard?

Noopur Raje, MD, Andrew J. Yee, MD
Journal: The Hematologist
The Hematologist (2017) 14 (4)
https://doi.org/10.1182/hem.V14.4.7450
Published: 2017
Articles

Peripheral Blood Genomic Interrogation in Myeloma: Developing a Blood Biopsy to Replace the Bone Marrow Biopsy

Jens G. Lohr, MD, PhD, Noopur Raje, MD, Andrew J. Yee, MD
Journal: The Hematologist
The Hematologist (2017) 14 (2)
https://doi.org/10.1182/hem.V14.2.7135
Published: 2017
Articles

Practice-Changing Daratumumab Combinations for the Treatment of Multiple Myeloma

Elizabeth O'Donnell, MD, Noopur Raje, MD, Andrew J. Yee, MD
Journal: The Hematologist
The Hematologist (2017) 14 (1)
https://doi.org/10.1182/hem.V14.1.7006
Published: 2017
Articles

Combining Daratumumab With Backbone Antimyeloma Agents

Elizabeth O'Donnell, MD, Noopur Raje, MD
Journal: The Hematologist
The Hematologist (2016) 13 (6)
https://doi.org/10.1182/hem.V13.6.6753
Published: 2016
Articles

Role of Salvage Autologous Transplant in Multiple Myeloma

Elizabeth O'Donnell, MD, Noopur Raje, MD
Journal: The Hematologist
The Hematologist (2016) 13 (5)
https://doi.org/10.1182/hem.V13.5.6436
Published: 2016
Articles

Checking Multiple Myeloma with Pembrolizumab

Noopur Raje, MD, Andrew J. Yee, MD
Journal: The Hematologist
The Hematologist (2016) 13 (4)
https://doi.org/10.1182/hem.V13.4.5637
Published: 2016
Articles

MRD Detection Testing to Study Clonal Selection and Drug Resistance

Elizabeth O'Donnell, MD, Noopur Raje, MD
Journal: The Hematologist
The Hematologist (2016) 13 (3)
https://doi.org/10.1182/hem.V13.3.5493
Published: 2016
Articles

Chimeric Antigen Receptor T Cells for the Treatment of Multiple Myeloma

Elizabeth O'Donnell, MD, Noopur Raje, MD
Journal: The Hematologist
The Hematologist (2016) 13 (2)
https://doi.org/10.1182/hem.V13.2.5107
Published: 2016
Articles

Novel Drugs Push the Envelope in Multiple Myeloma

Elizabeth O'Donnell, MD, Noopur Raje, MD, Andrew J. Yee, MD
Journal: The Hematologist
The Hematologist (2016) 13 (1)
https://doi.org/10.1182/hem.V13.1.4832
Published: 2016
Articles

Monoclonal Antibodies in the Treatment of Multiple Myeloma with a Focus on Elotuzumab and Daratumumab

Noopur Raje, MD, Andrew J. Yee, MD
Journal: The Hematologist
The Hematologist (2015) 12 (6)
https://doi.org/10.1182/hem.V12.6.4495
Published: 2015
Articles

New Clinical and Research Directions in Myeloma-Related Bone Disease

Loredana Santo, MD, Noopur Raje, MD
Journal: The Hematologist
The Hematologist (2015) 12 (5)
https://doi.org/10.1182/hem.V12.5.4355
Published: 2015
Articles

Do We Need Another HDAC Inhibitor in Multiple Myeloma?

Noopur Raje, MD, Andrew J. Yee, MD
Journal: The Hematologist
The Hematologist (2015) 12 (4)
https://doi.org/10.1182/hem.V12.4.4155
Published: 2015
Articles

Diagnostic Advances in Multiple Myeloma: The Role of Magnetic Resonance Imaging

Elizabeth O'Donnell, MD, Noopur Raje, MD
Journal: The Hematologist
The Hematologist (2015) 12 (3)
https://doi.org/10.1182/hem.V12.3.3910
Published: 2015
Articles

Transitioning to an All Oral Therapy for Multiple Myeloma with the Novel Proteasome Inhibitor Ixazomib

Noopur Raje, MD, Andrew J. Yee, MD
Journal: The Hematologist
The Hematologist (2015) 12 (2)
https://doi.org/10.1182/hem.V12.2.3679
Published: 2015